4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1-Reference-Cited by-同舟云学术

4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1

Published:2008-10-23 Issue:20 Volume:51 Page:6581-6591
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Menear Keith A.,Adcock Claire,Boulter Robert,Cockcroft Xiao-ling,Copsey Louise,Cranston Aaron,Dillon Krystyna J.,Drzewiecki Jan,Garman Sheila,Gomez Sylvie,Javaid Hashim,Kerrigan Frank,Knights Charlotte,Lau Alan,Loh Vincent M.,Matthews Ian T. W.,Moore Stephen,O’Connor Mark J.,Smith Graeme C. M.,Martin Niall M. B.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm8001263

Cited by 523 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and antitumor activities of phthalazinone derivatives as PARP-1 inhibitors and PARP-1/HDAC-1 inhibitors;Bioorganic Chemistry;2024-10

2. Between Theory and Practice: Computational/Experimental Integrated Approaches to Understand the Solubility and Lipophilicity of PROTACs;Journal of Medicinal Chemistry;2024-09-13

3. Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs;Journal of Medicinal Chemistry;2024-09-04

4. The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer;Medicinal Research Reviews;2024-08-24

5. A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway;ACS Pharmacology & Translational Science;2024-08-13